Andrews Research & Education Foundation   Report issue

Foundation Phase 1 Phase 3 Phase 4
Founded: Gulf Breeze FL United States (2014)

Organization Overview

First Clinical Trial
2015
NCT03290196
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Andrews Institute for Orthopaedic & Sports Medicine | Andrews Institute for Orthopaedics & Sports Medicine | Andrews Research & Education Foundation

Active Ingredients

Drugs in Phase 4 Trials (1)

bupivacaine (Exparel) (1 trial)

Drugs in Phase 3 Trials (2)

autologous plasma (1 trial)

hyaluronic acid (1 trial)

Drugs in Phase 1 Trials (1)

Filgrastim (neupogen) (1 trial)

Drugs in Other Trials (1)

leukocyte-rich platelet-rich plasma (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Anterior Cruciate Ligament Injuries (Phase 2)

Musculoskeletal Diseases (Phase 1)

Osteoarthritis (Phase 3)

Osteoarthritis, Knee (Phase 3)

Rotator Cuff Injuries (Phase 4)

Rupture (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 5